Our Privacy/Cookie Policy contains detailed information about the types of cookies & related technology on our site, and some ways to opt out. By using the site, you agree to the uses of cookies and other technology as outlined in our Policy, and to our Terms of Use.


CVS Is Selling an Alternative to EpiPen at a Sixth of the Price

Photograph by AFP/Getty Images

Many parents can now breathe a sigh of relief because CVS, the second-largest pharmacy in the country, announced that it is offering an authorized generic version of EpiPen called Adrenaclick for a sixth of the cost of the name-brand injector.

During the EpiPen fiasco that reached a fever pitch in August 2016, millions of people actively called for an alternative to the outrageously priced life-saving drug.

RELATED: Why Do So Many Kids Have Food Allergies Now?

Parents of kids suffering from life-threatening allergic reactions, or anaphylactic shock, expressed their outrage after hearing that Mylan, the pharmaceutical company behind EpiPen, increased the drug's price to more than $600 for a two-pack in the U.S. for those without insurance. This is a 500 percent hike from 2009, when the drug was $100 for a two-pack. After the outrage last year, Mylan launched a cheaper, generic version for $300 for a two-pack.

The total cost can be astronomical, when you consider that EpiPens should be replaced every 12 to 18 months and parents need multiple injectors.

As dad and Mom.me contributor Josh Adler, whose kid has a severe peanut allergy, wrote, "I hope you realize that we don’t need to just have ONE EpiPen. We need many. My wife has one on her at all times. I have one on me at all times. We have one at home at all times. My wife’s parents have one at their home. We need to have one at his elementary school and one at his after-school care."

It's not just one family who's affected by EpiPen prices. The Wall Street Journal reported about 3.6 million Americans were prescribed an EpiPen in 2015, and the Centers for Disease Control and Prevention reported more than 300,000 ambulatory-care visits occur every year for kids because of food allergies.

Adrenaclick, made by Impax Laboratories, is sold for a cash price of $109.99 for a two-pack (this is before potential discounts and rebates offered through Impax's patient assistant programs).

“We recognized the urgent need for a less-expensive epinephrine auto-injector, and are proud to offer a low-cost option at all CVS Pharmacy locations,” CVS said in a statement. The company will be offering Adrenaclick at “the lowest cash price in the market.”

Even the insurance company Cigna has announced it will turn toward Mylan's rivals.

Now that's what we call karma for the pharma.

"The generic version, available now in pharmacies, has the same drug formulation and device functionality as the branded medication, but at a substantial cost savings," Cigna spokeswoman Karen Eldred said in a statement.

But parents should carefully read instructions and know how to use Adrenaclick before leaving the pharmacy and consider scheduling a training session as well. That's because, according to Consumer Reports, Adrenaclick and EpiPen both contain the same drug in the same dosage, but they don't use the same technology. Incorrect usage could delay treatment or cause injury in an emergency.

RELATED: 4 Things Food Allergy Moms Want You to Know

Meanwhile, other generic versions are making headway. Kaleo's Auvi-Q is set to launch in the first half of 2017 and San Diego-based company Adamis has refiled their epinephrine syringe.

This all doesn't look good for Mylan though. Thanks to some good, old-fashioned competition, the company is predicted to lose at least $800 million through 2018.

Now that's what we call karma for the pharma.

Share this on Facebook?

More from news